Jared M. Freedberg
General Counsel bei INTERCEPT PHARMACEUTICALS, INC.
Profil
Jared M.
Freedberg is currently working as the General Counsel at Intercept Pharmaceuticals, Inc. and as the Secretary & General Counsel at Arvinas, Inc. He previously worked as the Secretary & General Counsel at Immunomedics, Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-Business Development & Strategy at Labcorp Drug Development, Inc. from 2014 to 2016 and Vice President-Legal & Business Development at Mallinckrodt LLC from 2016 to 2018.
Mr. Freedberg completed his undergraduate studies at the University of Pennsylvania and obtained his graduate degree from Duke University School of Law.
Aktive Positionen von Jared M. Freedberg
| Unternehmen | Position | Beginn |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | General Counsel | 11.01.2021 |
| ARVINAS, INC. | General Counsel | 16.01.2024 |
Ehemalige bekannte Positionen von Jared M. Freedberg
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOMEDICS, INC. | General Counsel | 01.12.2020 |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | General Counsel | 01.09.2018 |
| COVANCE INC. | Corporate Officer/Principal | 01.11.2016 |
Ausbildung von Jared M. Freedberg
| University of Pennsylvania | Undergraduate Degree |
| Duke University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ARVINAS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Health Technology |
